SCHEMBL7459901

SCHEMBL7459901

CN(C)c1cccc(/C=C2/SC(=O)NC2=O)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 2/20 1.00
PIM1 P11309 10/20 0.73
PIM2 Q9P1W9 10/20 0.73
AKR1B1 P15121 4/20 0.63
CISD1 Q9NZ45 3/20 0.63
MAOA P21397 1/20 0.63
MAOB P27338 1/20 0.63
PIM3 Q86V86 1/20 0.62
TTR P02766 1/20 0.59
CRHBP P24387 1/20 0.58
CRHR2 Q13324 1/20 0.58
IGF1R P08069 2/20 0.58
HPGD P15428 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7459904 1.00 GSK3B (1.00) GSK3BPIM1PIM2AKR1B1CISD1
SCHEMBL1248777 0.85 PIM1 (1.00) GSK3BPIM1PIM2AKR1B1CISD1
SCHEMBL1248775 0.85 PIM1 (1.00) GSK3BPIM1PIM2AKR1B1CISD1
SCHEMBL2544392 0.85 PIM1 (1.00) GSK3BPIM1PIM2AKR1B1CISD1
SCHEMBL7459912 0.83 GSK3B (0.71) GSK3BPIM1PIM2AKR1B1CISD1
SCHEMBL2539680 0.81 PIM1 (1.00) GSK3BPIM1PIM2AKR1B1CISD1
SCHEMBL2539679 0.81 PIM1 (1.00) GSK3BPIM1PIM2AKR1B1CISD1
SCHEMBL2539676 0.81 PIM1 (1.00) GSK3BPIM1PIM2AKR1B1CISD1
SCHEMBL24991901 0.79 PIM1 (0.67) GSK3BPIM1PIM2AKR1B1CISD1
SCHEMBL1250348 0.79 PIM1 (1.00) GSK3BPIM1PIM2AKR1B1CISD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1214305-A1 BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF INFLAMMATION Maxia Pharmaceuticals, Inc. (US) 2002-06-19 EP claimed
WO-2001016123-A1 BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF INFLAMMATION MAXIA PHARMACEUTICALS, INC. (US) 2001-03-08 WO claimed